Wiktor Komenda

Mr. Wiktor Komenda

Institute of Nuclear PhysicsPolish Academy of Sciences
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BKBartosz Klebowski
Bartosz Klebowski
JDJoanna Depciuch
Joanna Depciuch
MSMalgorzata Stec
Malgorzata Stec
DKDawid Krzempek
Dawid Krzempek
WKWiktor Komenda
Wiktor Komenda
MPMagdalena Parlinska-Wojtan
Magdalena Parlinska-Wojtan
Enhancing the effectiveness of colorectal cancer treatment is highly desirable. Radiation-based anticancer therapy—such as proton therapy (PT)—can be used to shrink tumors before subsequent surgical intervention; therefore, improving the effectiveness of this treatment is crucial. The addition of noble metal nanoparticles (NPs), acting as radiosensitizers, increases the PT therapeutic effect. Thus, in this paper, the effect of novel, gold–platinum nanocauliflowers (AuPt NCs) on PT efficiency is determined. For this purpose, crystalline, 66-nm fancy shaped, bimetallic AuPt NCs were synthesized using green chemistry method. Then, physicochemical characterization of the obtained AuPt NCs by transmission electron microscopy (TEM), selected area electron diffraction (SAED), energy dispersive X-ray spectroscopy (EDS), and UV-Vis spectra measurements was carried out. Fully characterized AuPt NCs were placed into a cell culture of colon cancer cell lines (HCT116, SW480, and SW620) and a normal colon cell line (FHC) and subsequently subjected to proton irradiation with a total dose of 15 Gy. The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) test, performed after 18-h incubation of the irradiated cell culture with AuPt NCs, showed a significant reduction in cancer cell viability compared to normal cells. Thus, the radio-enhancing features of AuPt NCs indicate their potential application for the improvement in effectiveness of anticancer proton therapy.

29 November 2022 in Cancers
Verified
Journal Article
Open access
PDF file
BKBartosz Klebowski
Bartosz Klebowski
MSMalgorzata Stec
Malgorzata Stec
JDJoanna Depciuch
Joanna Depciuch
APAgnieszka Panek
Agnieszka Panek
DKDawid Krzempek
Dawid Krzempek
MPMagdalena Parlinska-Wojtan
Magdalena Parlinska-Wojtan
Nano-sized radiosensitizers can be used to increase the effectiveness of radiation-based anticancer therapies. In this study, bimetallic, ~30 nm palladium-platinum nanoparticles (PdPt NPs) with different nanostructures (random nano-alloy NPs and ordered core-shell NPs) were prepared. Scanning transmission electron microscopy (STEM), selected area electron diffraction (SAED), energy-dispersive X-ray spectroscopy (EDS), zeta potential measurements, and nanoparticle tracking analysis (NTA) were used to provide the physicochemical characteristics of PdPt NPs. Then, PdPt NPs were added to the cultures of colon cancer cells and normal colon epithelium cells in individually established non-toxic concentrations and irradiated with the non-harmful dose of X-rays/protons. Cell viability before and after PdPt NPs-(non) assisted X-ray/proton irradiation was evaluated by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay. Flow cytometry was used to assess cell apoptosis. The results showed that PdPt NPs significantly enhanced the effect of irradiation on cancer cells. It was noticed that nano-alloy PdPt NPs possess better radiosensitizing properties compared to PtPd core-shell NPs, and the combined effect against cancer cells was c.a. 10% stronger for X-ray than for proton irradiation. Thus, the radio-enhancing features of differently structured PdPt NPs indicate their potential application for the improvement of the effectiveness of radiation-based anticancer therapies.

14 July 2025 in Physics in Medicine & Biology
Verified
Journal Article
Open access
AWAgnieszka Wochnik
Agnieszka Wochnik
DBDamian Borys
Damian Borys
GFGabriela Foltyńska
Gabriela Foltyńska
JGJan Gajewski
Jan Gajewski
MGMagdalena Garbacz
Magdalena Garbacz
ARAntoni Rucinski
Antoni Rucinski
Objective. Cyclotron Centre Bronowice Krakow proton therapy center is establishing a methodology for dosimetric evaluation to support treatments of moving targets, particularly in the mediastinal area. We propose a robust 4D Monte Carlo (MC) dose evaluation approach for proton treatment plans, integrating temporal information on both pencil beam delivery and organ motion in the context of free-breathing treatments. Approach. A specialized tool combining the GPU-accelerated FRED MC code and temporal patient and treatment delivery data was developed. The methodology includes standard 3D dose evaluation for setup and CT calibration uncertainties, plan recalculation across respiratory phases, and robust 4D dose evaluation (4DDE). The 4DDE approach accumulates dose over deformable respiratory phases using log file time information to assess treatment plans at various respiratory cycle starting points. Validation used anonymized 4D computed tomography scans from a Hodgkin lymphoma patient, with deformable image registration extracting motion vector fields. For reference, proton plans were also recalculated on the median tumor position phase image and results were analyzed for dose–volume histograms parameters variability, 3D gamma index (GI) analysis (3%/3 mm) and voxel-wise worst case scenario, relative to the reference treatment planning system calculation. Main results. Exemplary robust 4DDE revealed that considering time provides insight into the worst-case scenarios, resulting in wider dose ranges (GI 55.05% to 88.36% vs 48.26% to 92.92% for 3D and 4D analysis, respectively). The voxel-wise worst-case dose distribution showed reduced target coverage by 47.4% and 20.8% (for 95% and 90% isodose) when accounting for respiratory motion. Significance. The study introduces a fast tool for 4DDE, demonstrating versatility ensures robustness in 3D and 4D evaluations, underscoring the significance of dynamic anatomical considerations in 4D proton radiotherapy.

3 September 2025 in Physica Medica
Verified
Journal Article
Open access
WKWiktor Komenda
Wiktor Komenda
NMNatalia Mojżeszek
Natalia Mojżeszek
MBMarta Bałamut
Marta Bałamut
JGJan Gajewski
Jan Gajewski
HJHubert Jabłoński
Hubert Jabłoński
ARAntoni Ruciński
Antoni Ruciński
Experimental patient-specific quality assurance (PSQA) in proton therapy is a labor-intensive process requiring physical access to treatment rooms, beam time, and significant human resources. With the increasing complexity of treatment plans and the implementation of adaptive therapy, the need for efficient alternatives is pressing. Simulation-based techniques are proposed as a replacement or enhancement for experimental ones. This study presents a data-driven approach to simulation-based PSQA criteria selection and validation. The FRED Monte Carlo code was used to simulate PSQA for 293 patients (Gantry 1) and 296 patients (Gantry 2), divided into training and verification subsets. The training dataset guided criteria selection for simulation-based PSQA. The gamma index (GI) was analysed with criteria of 3 %/2 mm, 2 %/2 mm, 1.75 %/2 mm, 1.5 %/2 mm and 1.25 %/2 mm and compared to experimental PSQA through Spearman's rank test. Both GI criteria and passing rate thresholds were tested to maximize consistency between experimental and simulation-based PSQA and to minimize the likelihood of false-positive errors. We validated the selected criterion on the verification subset. The analysis identified the 1.75 %/2mm GI criterion with a 95 % passing rate as optimal. Validation on an independent verification dataset of 2816 planes showed high consistency between simulation-based and experimental PSQA: 97.5 % agreement for Gantry 1 and 98.6 % for Gantry 2. False positives were eliminated for Gantry 1 and reduced to 0.5 % for Gantry 2. The proposed approach demonstrates its potential to streamline PSQA workflows, maintain clinical accuracy, and enable the integration of simulation-based PSQA into routine practice.

14 June 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MGMagdalena Garbacz
Magdalena Garbacz
TSTomasz Skóra
Tomasz Skóra
ACAnna Cepiga
Anna Cepiga
GFGabriela Foltyńska
Gabriela Foltyńska
JGJan Gajewski
Jan Gajewski
RKRenata Kopec
Renata Kopec
Background: This work presents the procedures and application of the deep inspiration breath-hold (DIBH) technique for mediastinal lymphoma patients at a proton therapy (PT) center. It also discusses the implementation and validation of the surface-guided radiotherapy (SGRT) protocol in terms of positioning accuracy. Methods: This study included six lymphoma patients. Dedicated computed tomography (CT) protocols and a treatment workflow based on international guidelines were developed. Clinical data from the treatment planning system (TPS) were used to assess the difference between DIBH and free-breathing irradiation. Additionally, data from an optical patient positioning system and kilovoltage (kV) imaging system were used to estimate positioning shifts. The new CT protocol reduced the volume CT dose index by over six times compared with the standard protocol. Results: The DIBH method decreased the mean dose to the heart and lungs by up to 7.02 Gy(RBE) and 0.83 Gy(RBE), respectively. The median magnitude of patient setup errors and repeatability in DIBH positioning was 0.4 cm and 0.18 cm (mean for males and females) for the SGRT protocol. The kV imaging showed a setup error of over 0.3 cm for both groups. Conclusions: Despite the small size of the patient cohort, the relatively large number of individual positioning sessions enabled the detection of statistically significant differences (p < 0.05) in certain areas between male and female patients; however, no significant difference in the displacement vector magnitude was observed. DIBH treatment with SGRT offers high reproducibility for patient positioning.